ANI Pharmaceuticals offers an asymmetric opportunity in small-cap pharma, with a niche in generics, rare disease treatments, ...

Biohaven's NDA for Troriluzole was accepted by the FDA, potentially leading to approval in Q3 2025. Click here to find out ...

Rising air pollution, changes in hormone levels, immune system imbalances and longer life expectancy are increasing the risk ...

The table below is a review of notable updates that occurred in January 2025 for investigational products in development.

Bio-Thera will obtain an upfront payment of $21m and could earn up to $143.5m in development and commercial milestones.

StockNews.com started coverage on shares of Syros Pharmaceuticals (NASDAQ:SYRS – Get Free Report) in a research note issued ...

Arvinas Inc. (ARVN) reported its earnings for the fourth quarter of 2024, revealing a smaller-than-expected loss per share ...

Researchers at the Center for Life Sciences at the Paul Scherrer Institute PSI have for the first time identified structural changes in the botulinum ...

Our eyes never stay completely still - even when we try to hold our gaze steady. These tiny, involuntary movements were long thought to blur our ...

Lung cancer cases are increasing in people who have never smoked, especially in women, a new study by the World Health Organization's cancer agency ...